Here are relevant reports on : mesoporous-silica-nanoparticles-market
-
Fumed Silica Market by Type (Hydrophilic Fumed Silica and Hydrophobic Fumed Silica), Application (Silicone Elastomers, Paints, Coatings & Inks, Adhesives & Sealants, UPR & Composites), End-use Industry and Region - Global Forecast to 2030
The fumed silica market is expected to reach USD 2.14 billion by 2030 from USD 1.80 billion in 2025, at a CAGR of 3.46% during the forecast period. The report profiles key companies, including Evonik Industries AG (Germany), Wacker Chemie AG (Germany), Cabot Corporation (US), Tokuyama Corporation (Japan), OCI Company Ltd. (South Korea), Dongyue Group (China), Hoshine Silicon Industry Co., Ltd. (China), Hubei Xingfa Chemicals Group Co., Ltd. (China), Hubei Huifu Nanomaterial Co., Ltd. (China), Xunyu Group (China), and Applied Material Solutions (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Vacuum Insulation Panels Market by Core Material Type (Silica, Fiberglass, others), Type (Flat, Special Shape), Raw material (Silica, Fiberglass, Plastic, Metal, others), Application (Construction, Cooling & freezing devices, Logistics, Others) - Forecast to 2021
The market for vacuum insulation panels is projected to grow from USD 6.38 Billion in 2016 to reach USD 8.14 Billion by 2021, at a CAGR of 4.99%. The report aims at estimating the market size and future growth potential of the vacuum insulation panels market across different segments such as core material, type, raw material, application, and region. Globally, competition in the vacuum insulation panels market is growing considerably owing to the growing construction and consumer durables industries. With the emergence of new technologies, manufacturers are looking for advanced techniques to make vacuum insulation panels more effective. The base year considered for the study is 2015 and the market size is projected from 2016 to 2021.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Specialty Silica Market - By Type, Application & Geography - 2018
Specialty Silica Market
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029
The gold nanoparticles market is expected to grow from USD 0.50 billion in 2024 to USD 1.11 billion in 2029, at a CAGR of 16.3% during the forecast period. Prominent companies include BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), and among others.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Cerium Oxide Nanoparticles Market by Form (Dispersion and Powder), Application (Chemical Mechanical Planarization, Catalyst, Biomedical, Energy), and Region (North America, APAC, Europe, and RoW) - Global Forecast to 2022
The cerium oxide nanoparticles market is projected to reach USD 630.2 Million by 2022 from USD 259.7 Million in 2017, at a CAGR of 19.4% from 2017 to 2022. The high demand for cerium oxide nanoparticles from the CMP application especially in North America is driving the growth of the global cerium oxide nanoparticles market. Cerion (US), Plasmachem (Germany), American Elements (US), Inframat Advanced Materials (US), NYACOL Nano Technologies (US), and Nanophase Technologies (US), are some of the leading players operating in the cerium oxide nanoparticles market. These companies are adopting various strategies, such as expansions, new product launches, and partnerships to increase their market shares and strengthen their position in the cerium oxide nanoparticles market
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
3D Printed Drugs Market by Dosage Form (Tablet, Capsule, Nanoparticles), Technology (Inkjet Printing, Zipdose, Direct Write, Stereolithography, Fused Deposition Modeling), Application (Orthopedic, Neurology, Dental) - Global Forecast to 2027
The global 3D Printed Drugs market is projected to reach USD 110 million by 2027 from ~USD 50 million in 2022, at a CAGR of 17% during the forecast period
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Metal Nanoparticles Market by Metal (Platinum, Gold, Silver, Iron, Copper, Nickel), Process (Chemical, Physical), End-use (Pharmaceutical & Healthcare, Electrical & electronics, Catalyst, Personal care & cosmetics) and Region - Global Forecast to 2026
The metal nanoparticles market is expected to grow from USD 2.4 billion in 2021 to USD 4.2 billion by 2026, at a CAGR of 11.5% during the forecast period. Major players operating in the global metal nanoparticles market include American Elements (US), Nanoshel LLC (US), Nanostructured & Amorphous Materials (US), EPRUI Nanoparticles & Microspheres (China), US Research Nanomaterials (US), Tanaka Holdings (Japan), Meliorum Technology (US), Nanocomposix (US), BBI Group (UK), Sigma-Aldrich (US), and Nanocs (US) among many others.
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
Asia Pacific Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The Asia Pacific injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period. The growth of the Asia Pacific injectable drug delivery market is driven by the increasing incorporation of biologics, biosimilars, and long-acting injectables, alongside a rapidly growing patient population and an escalating burden of chronic diseases across major countries in the region.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
APAC Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The APAC injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
